Small Pharma Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DMTTF research report →
Price Chart
About the company
Small Pharma Inc. is a biotechnology firm focused on developing fast-acting psychedelic therapies, coupled with supportive psychological care, to address mental health conditions. Its flagship clinical initiative centers on N,N-dimethyltryptamine (DMT) assisted therapy designed to combat major depressive disorder.
- CEO
- George Tziras
- IPO
- 2021
- HQ
- London, GB
Get TickerSpark's AI analysis on DMTTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $37.51M
- P/E
- -2.17
- PEG
- 0.15
- P/S
- 0.00
- P/B
- 2.88
- EV/EBITDA
- -1.37
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -78.43%
- ROIC
- -128.32%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-24,680,068
- Net Income
- $-22,836,213-2.6%
- EPS
- $-0.07+0.7%
- OCF Growth
- -36.8%
- FCF Growth
- -36.9%
- 52W High
- $0.19
- 52W Low
- $0.04
- 50D MA
- $0.09
- 200D MA
- $0.07
- Beta
- 0.85
- RSI (14)
- 49
- Avg Volume
- 109.35K
No earnings-call transcripts are available for DMTTF yet.
- Free Float
- 100.0%
- Shares Outstanding
- 335.77M
- Float Shares
- 335.77M
Our DMTTF coverage
Recent articles, reports, and earnings notes.
No research on DMTTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate DMTTF report →Small Pharma Reports Fiscal Second Quarter 2024 Highlights
globenewswire.com · Oct 19
Small Pharma Announces Voting Results from Annual General and Special Meeting of Shareholders
globenewswire.com · Oct 12
Disposition of Common Shares of Small Pharma Inc.
globenewswire.com · Oct 2
Small Pharma Reports Positive Top-line Data from SPL026 (DMT)-SSRI Drug Interaction Study in Patients with Major Depressive Disorder
globenewswire.com · Sep 26
Cybin to Acquire Small Pharma Inc.
newsfilecorp.com · Aug 28
Small Pharma Reports Fiscal First Quarter 2024 Highlights
globenewswire.com · Jul 27
Small Pharma to Present at Upcoming CINP World Congress of Neuropsychopharmacology
globenewswire.com · May 3
Small Pharma to Present at Cowen's 43rd Annual Health Care Conference
globenewswire.com · Mar 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.